European Association for Hemophilia and Allied Disorders (EAHAD 2026) 3 - 6 February 2026

Concizumab plasma concentration measurements and modelling for personalised dose adjustment in patients with haemophilia A/B with and withoutot inhibitors

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Rare Endocrine Disorder
Congress oral presentation
Concizumab